UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rules 13a-16 or 15d-16 under
the Securities Exchange Act of 1934
For the month of November 2021
Commission File Number: 001-38836
BIOCERES CROP SOLUTIONS CORP.
(Translation of registrant’s name into English)
Ocampo 210 bis, Predio CCT, Rosario
Province of Santa Fe, Argentina
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F x
Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Bioceres Crop Solutions
Announces Regulatory Approval of Drought Tolerant HB4® Wheat by Brazil’s CTNBio
Company Achieves Industry Milestone
as Approval Grants Headway
Towards First-Ever Commercialization
of Biotech Wheat
ROSARIO, Argentina –
November 11, 2021 – Bioceres Crop Solutions Corp. (“Bioceres”) (NASDAQ: BIOX), a fully integrated global provider
of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, has received import approval
of the Company’s HB4 Wheat flour for animal and human consumption from Brazil’s Ministry of Agriculture, Livestock and Food
Supply.
After a rigorous review process
that included the use of OMICS datasets to support the scientific safety evaluation of HB4 Wheat, the Brazilian National Biosafety Commission
(CTNBio) – an agency that encompasses recognized scientists and diverse specialists – unanimously endorsed biosafety conditions
for flour obtained from HB4 Wheat. The comprehensive regulatory process involved the development of state-of-the-art methodologies by
Bioceres, to address allergenic risk concerns and demonstrate the safety equivalence of HB4 wheat to its conventional counterpart.
This approval is a major step
towards building climate resilient agriculture systems that use wheat as a key component for crop rotation. Wheat is a key staple for
billions of people around the globe, and a crop, that has remained orphan in the sphere of biotechnology despite being planted in 200
million hectares globally. In October of 2020, Argentina granted first approval of HB4 Wheat ‘event’ for growth and consumption.
The commercialization of HB4 wheat in Argentina has been subject to Brazilian approval, as Brazil is the main export market for Argentinean
wheat production. Argentina is the largest wheat producing country in the southern cone resulting in an annual opportunity of 6-8 million
hectares.
Meaningful resources and efforts
have backed this significant milestone, which could not have been accomplished without the continued support of Bioceres partner Tropical
Melhoramento & Genética, a Brazilian partner who lead the regulatory filings with CTNBio and Florimond Desprez the co-developer
of HB4 Wheat and a Bioceres partner in Trigall Genetics, the trust of our shareholders, and the strong commitment of the teams involved
in the entire research, development and regulatory processes.
Bioceres has been scaling-up HB4
Wheat inventories through its identity-preserved HB4 Program and is currently harvesting 55,000 hectares of the crop. Considering inventory
availability for next planting season and the significance of this regulatory milestone regarding its commercial prospects, the Company
will update the investors community with 2022 acreage projections and business opportunity in its next earnings call.
About Bioceres Crop Solutions
Corp.
Bioceres Crop Solutions
Corp. (NASDAQ: BIOX) is a fully integrated provider of crop productivity technologies designed to enable the transition of agriculture
towards carbon neutrality. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt
environmentally friendlier production practices. The Company has a unique biotech platform with high-impact, patented technologies for
seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4® program, the Company
is bringing digital solutions to support growers’ decisions and provide end-to-end traceability for production outputs. For more
information, visit here.
Forward-Looking
Statements
This
communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the
United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such
as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,”
“expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions
that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements are
based on management’s reasonable current assumptions, expectations, plans and forecasts regarding the Company’s current or
future results and future business and economic conditions more generally. Such forward-looking statements involve risks, uncertainties
and other factors, which may cause the actual results, levels of activity, performance or achievement of the Company to be materially
different from any future results expressed or implied by such forward-looking statements, and there can be no assurance that actual results
will not differ materially from management’s expectations or could affect the Company’s ability to achieve its strategic goals,
including the uncertainties relating to the impact of COVID-19 on the Company’s business, operations, liquidity and financial results
and the other factors that are described in the sections entitled “Risk Factors” in the Company's Securities and Exchange
Commission filings updated from time to time. The preceding list is not intended to be an exhaustive list of all of our forward-looking
statements. Therefore, you should not rely on any of these forward-looking statements as predictions of future events. All forward-looking
statements contained in this release are qualified in their entirety by this cautionary statement. Forward-looking statements speak only
as of the date they are or were made, and the Company does not intend to update or otherwise revise the forward-looking statements to
reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, except as required
by law.
Contacts
Investor Relations Contact
Chris Tyson
Executive Vice President
MZ Group – MZ North America
(949) 491-8235
BIOX@mzgroup.us
www.mzgroup.us
Bioceres Crop Solutions
Rodrigo Krause
Head of Investor Relations
investorrelations@biocerescrops.com
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
BIOCERES CROP SOLUTIONS CORP.
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
Dated: November 15, 2021
|
By:
|
By:
|
/s/ Federico Trucco
|
|
|
Name:
|
Federico Trucco
|
|
|
Title:
|
Chief Executive Officer
|
Bioceres Crop Solutions (NASDAQ:BIOX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioceres Crop Solutions (NASDAQ:BIOX)
Historical Stock Chart
From Jul 2023 to Jul 2024